bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.02.14.705923

Focal Neurostimulation of Calcium Signaling and Dopamine Release in Human Dopaminergic Neurons Using Megahertz-range Single-Pulse Focused Ultrasound

Abstract

Focused Ultrasound (FUS) neurostimulation has increasingly attracted attention given its ability for localized targeting and non- to minimally-invasive capacity. However, the understanding of the biological and neurochemical mechanisms triggered by this neurostimulation modality remains limited. Indeed, further progress of this technology could benefit from spatiotemporal evaluation of neurotransmitter secretory activity resulting from FUS stimulation. Recently, we demonstrated in-vitro the ability of FUS to evoke calcium (Ca2+) waves, in a mixture of human neuronal and glial cells (standard cells), with single-pulse megahertz-range FUS compatible with a transdural approach relying on an intracranial FUS implant. In the present work, we investigated the ability to evoke Ca2+ signaling and dopamine (DA) release by single-pulse megahertz-range FUS stimulation of cultured human dopaminergic neurons in-vitro. A hybrid-platform integrating a custom-made FUS implant prototype (concave spherical transducer, O and focal distance: 15 mm) with real-time Ca2+ fluorescence microscopy imaging (FMI), and fast scan cyclic voltammetry (FSCV) was constructed to evaluate FUS-evoked Ca2+ signaling and concurrent DA release. Ca2+ and DA releases evoked by FUS on dopaminergic neurons (DA neurons) were compared to those evoked in standard cells. Application of single-pulse FUS (frequency: 5.11 MHz, pulse duration: 700 {micro}s, spatial average pulse average intensity, Isapa: 19.59 {+/-} 4.12 W.cm-2) was shown to causally mobilize Ca2+ dynamics in both cell types. Immediate (< 1 s) responses were focally evoked in cell clusters of 290 {micro}m in diameters; corresponding to the -3 dB FUS focal diameter. However, while standard cells exhibited continuous and omnidirectional delayed propagating dynamics following FUS stimulation, DA neurons showed more spatially sparse responses. The FUS-induced Ca2+ activity in DA neurons was accompanied by DA release detected by FSCV, but not in standard cells. This study demonstrates that single-pulse megahertz-range FUS induced with an intracranial implant prototype smaller than conventionally used FUS devices (transcranial applications) can evoke in-vitro intracellular Ca2+ activity while stimulating DA release from dopaminergic neurons, underscoring its potential as a neuro-stimulation/-modulation tool for targeting dopaminergic circuits in various pathologies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Khodayari, S., Suarez-Castellanos, I., Perier, M., Aubier, T., Hashemi, P., Carpentier, A., Marinesco, S., N'Djin, W. A.. 2026-02-17. Focal Neurostimulation of Calcium Signaling and Dopamine Release in Human Dopaminergic Neurons Using Megahertz-range Single-Pulse Focused Ultrasound. https://doi.org/10.64898/2026.02.14.705923

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Surfactant-Assisted Colorimetric Signal Enhancement in Paper-Based Glucose Sensing

Paper-based colorimetric sensors offer a low-cost and accessible platform for point-of-care (POC) analysis, but enzyme activity loss during coating and drying can weaken analytical signals and require high enzyme loadings or complex immobilization procedures. Although surfactants are widely used to improve wettability in paper-based assays, their potential contribution to colorimetric performance beyond these effects remains unclear. Here, we investigated surfactant-assisted colorimetric signal enhancement in a glucose assay implemented on a 96-puddle paper plate (96-PPP) and identified Tween 20 as the most effective surfactant. Its effect on detection performance became more pronounced as glucose oxidase (GOx) loading decreased; at 0.1 mg/mL GOx, Tween 20 lowered the limit of detection (LoD) from 0.113 to 0.034 mg/mL (approximately 3.3-fold) over a working range of 0-5 mg/mL, despite no statistically significant change in the measured contact angle at this loading. Tween 20 had no appreciable effect on the reaction in solution but preserved 95% of the apparent reaction rate constant after drying, compared with 11% without it, and atomic force microscopy (AFM) revealed a more dispersed dried enzyme morphology on mica. Tween 20-containing sensors also showed slower signal decay during repeated wetting-drying cycles and thermal stress, retained 77% (vs 26%) of the response at 400 mM NaCl, and exhibited within-PPP and between-batch coefficients of variation (CVs) below 10% (vs 12.3-19.5%), while maintaining glucose selectivity over potentially interfering molecules. These results indicate that Tween 20 enhances paper-based glucose sensing beyond wettability, in part by retaining enzyme cascade activity during drying, although the contributions of the individual enzymes and the underlying mechanism remain to be established.

bioengineering↗

Engineering CAR-T cells to remodel the mucin-rich cancer cell glycocalyx

The dense glycocalyx of cancer cells can restrict immune-cell access to surface antigens and limit CAR-T cell activity. Here, we show that mucin density and epitope position determine how glycocalyx remodeling affects CAR-T cell recognition and killing. We identify KLK5 as a human protease that cleaves tumor-associated mucins, increases access to membrane-proximal antigens, and enhances CAR-T cell function. We then engineer CAR-T cells to display or secrete KLK5, enabling remodeling of the tumor glycocalyx during antigen recognition. KLK5-engineered CAR-T cells improved tumor control across multiple xenograft models, and KLK5-secreting MUC17 CAR-T cells produced the strongest in vivo benefit, prolonging survival compared with conventional MUC17 CAR-T cells. These findings show that CAR-T cells can be engineered to breach the mucin-rich glycocalyx while preserving accessible target epitopes.

bioengineering↗

Wall stiffening is a primary contributor to motility loss in Crohn's disease: an electromechanical modeling study

Fibrotic strictures are among the most disabling complications of Crohn's disease, permanently narrowing the bowel and impairing motility, yet no approved therapy reverses them. Chronic inflammation alters pacemaker-network coupling, smooth-muscle excitability, and calcium-dependent contractility, while fibrosis thickens the bowel wall, narrows the lumen, and changes tissue mechanics. The relative contributions of these coupled electrical, contractile, and structural alterations to motility loss remain unclear. To address this gap, we develop an integrated electromechanical finite-element framework for fibrostenosing Crohn's disease that couples a fibrosis-driven growth model with a FitzHugh-Nagumo electromechanical model. A full-factorial 25 design of experiments is used to quantify the relative effects of electrical diffusivity, excitation threshold, peak active stress, wall stiffness, and hypertrophic remodeling on cyclic lumen-volume deformation. Motility is quantified by the standard deviation of lumen volume over one contraction cycle. Within the parameter ranges examined, increased wall stiffness emerged as the dominant contributor to motility loss, followed by impaired smooth-muscle contractility. Changes in excitation threshold, hypertrophic remodeling, and electrical diffusivity produced substantially smaller effects. Pairwise interactions were small relative to the dominant main effects, indicating that the mechanisms contributed largely through their individual effects. Our findings suggest that limiting wall stiffening while preserving smooth-muscle contractile function may provide a therapeutic strategy for maintaining intestinal motility in fibrostenosing Crohn's disease.

bioengineering↗